新型青霉烯抗生素CP-70429的体外抗菌活性及β-内酰胺酶稳定性
In vitro antibacterial activity and beta-lactamase stability of CP-70,429 a new penem antibiotic.
作者信息
Minamimura M, Taniyama Y, Inoue E, Mitsuhashi S
机构信息
Episome Institute, Gunma, Japan.
出版信息
Antimicrob Agents Chemother. 1993 Jul;37(7):1547-51. doi: 10.1128/AAC.37.7.1547.
In in vitro susceptibility tests, the new penem CP-70,429 showed potent antibacterial activity against gram-positive and gram-negative bacteria except Pseudomonas aeruginosa and Xanthomonas maltophilia. CP-70,429 was stable to various types of beta-lactamases except for the enzyme from X. maltophilia and was 16- to 128-fold more active than the other compounds against beta-lactamase-producing strains of Enterobacter cloacae and Citrobacter freundii.
在体外药敏试验中，新型青霉烯类药物CP - 70,429对革兰氏阳性菌和革兰氏阴性菌显示出强大的抗菌活性，但对铜绿假单胞菌和嗜麦芽窄食单胞菌除外。CP - 70,429对除嗜麦芽窄食单胞菌产生的酶以外的各种β - 内酰胺酶稳定，并且对阴沟肠杆菌和弗氏柠檬酸杆菌的产β - 内酰胺酶菌株的活性比其他化合物高16至128倍。
Zotero 插件